Bayesian Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,700
| Closed | -$54K | – | 880 |
|
|
2024
Q4 | $54K | Buy |
+17,700
| New | +$54K | 0.01% | 630 |
|
|
2023
Q1 | – | Sell |
-11,901
| Closed | -$50.3K | – | 1020 |
|
|
2022
Q4 | $50.3K | Buy |
+11,901
| New | +$50.3K | 0.01% | 704 |
|
|
2020
Q3 | – | Sell |
-10,700
| Closed | -$112K | – | 649 |
|
|
2020
Q2 | $112K | Buy |
+10,700
| New | +$112K | 0.02% | 473 |
|
|
2020
Q1 | – | Sell |
-17,019
| Closed | -$149K | – | 928 |
|
|
2019
Q4 | $149K | Buy |
+17,019
| New | +$149K | 0.03% | 554 |
|
|
2019
Q3 | – | Sell |
-15,000
| Closed | -$191K | – | 645 |
|
|
2019
Q2 | $191K | Sell |
15,000
-3,575
| -19% | -$45.5K | 0.04% | 443 |
|
|
2019
Q1 | $721K | Buy |
+18,575
| New | +$721K | 0.14% | 209 |
|
|
2018
Q2 | – | Sell |
-7,500
| Closed | -$510K | – | 683 |
|
|
2018
Q1 | $510K | Buy |
+7,500
| New | +$510K | 0.13% | 264 |
|